That time again: The 20 best hospitals in the US

Mayo Clinic is No. 1 on the list of top hospitals for 2021, as ranked by U.S. News and World Report.

The Rochester, Minnesota-based hospital system owns 19 hospitals in Minnesota, Wisconsin and Iowa and has been consistently ranked as a top hospital for many years. U.S. News & World Report has put out its list of the best hospitals in the U.S. for the last 30 years. 

The list takes numerous considerations into account to rank hospitals, including 17 bellwether procedures and conditions, such as knee replacement, heart bypass surgery, Back surgery, diabetes, heart attack, hip fracture, kidney failure, pneumonia and stroke.

Here are the top 20 best hospitals for 2021:

1. Mayo Clinic, Rochester, Minnesota.

2. Cleveland Clinic.

3. UCLA Medical Center, Los Angeles.

4. Johns Hopkins Hospital, Baltimore.

5. Massachusetts General Hospital, Boston.

6. Cedars-Sinai Medical Center, Los Angeles.

7. New York-Presbyterian Hospital-Columbia and Cornell, New York.

8. NYU Langone Hospitals, New York.

9. UCSF Medical Center, San Francisco.

10. Northwestern Memorial Hospital, Chicago.

11. University of Michigan Hospitals-Michigan Medicine, Ann Arbor.

12. Stanford Health Care-Stanford Hospital, Stanford, California.

13. Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia.

14. Brigham and Women's Hospital, Boston.

15. Mayo Clinic-Phoenix.

16. Houston Methodist Hospital.

17. (tie) Barnes-Jewish Hospital, St. Louis.

17. (tie) Mount Sinai Hospital, New York.

19. Rush University Medical Center, Chicago.

20. Vanderbilt University Medical Center, Nashville.

 

See the full rankings here.

 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.